The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to other oral glucose-lowering medications in the treatment of type 2 diabetes

出版年份 2020 全文链接

标题

作者

关键词

出版物

Volume 109, Issue -, Pages 154295

出版商

Elsevier BV

发表日期

2020-06-15

DOI

10.1016/j.metabol.2020.154295

联系作者

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started